Such positive effects have been attributed to the oxaliplatin-induced secretion of T cell-attractive chemokines by tumor associated macrophages resulting in improved CAR-T cell infiltration, remodeling of the tumor microenvironment, and increased tumor sensitivity to anti-PD-L1 [251]. The gene discussed is CD274; the disease is neoplasm.